Black Diamond Therapeutics, Inc.
NASDAQ:BDTX
4.78 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 4.894 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.086 | 0.086 | 0.086 | 0.823 | 0.812 | 0.812 | 0.807 | 0.807 | 0.813 | 0.811 | 0.804 | 0.626 | 0.447 | 0.34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.086 | -0.086 | 4.808 | -0.823 | -0.812 | -0.812 | -0.807 | -0.807 | -0.813 | -0.811 | -0.804 | -0.626 | -0.447 | -0.34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.982 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 12.47 | 13.459 | 15.203 | 16.154 | 13.154 | 14.753 | 14.609 | 15.847 | 16.195 | 17.786 | 19.664 | 27.626 | 26.719 | 22.82 | 17.756 | 12.929 | 10.17 | 7.354 | 7.46 | 5.634 | 5.646 | 3.013 | 2.379 | 1.631 | 1.47 | 1.47 |
| General & Administrative Expenses
| 9.574 | 6.701 | 5.566 | 7.858 | 6.878 | 6.808 | 7.243 | 6.277 | 6.978 | 7.893 | 6.416 | 7.738 | 7.996 | 7.893 | 5.427 | 5.551 | 4.858 | 5.525 | 2.884 | 2.514 | 1.353 | 0.828 | 0.667 | 0.708 | 0.29 | 0.29 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 9.574 | 6.701 | 5.566 | 7.858 | 6.878 | 6.808 | 7.243 | 6.277 | 6.978 | 7.893 | 6.416 | 7.738 | 7.996 | 7.893 | 5.427 | 5.551 | 4.858 | 5.525 | 2.884 | 2.514 | 1.353 | 0.828 | 0.667 | 0.708 | 0.29 | 0.29 |
| Other Expenses
| 1.757 | 1.384 | 1.123 | 0.566 | 0.341 | 0.064 | 0.115 | -0.092 | -0.143 | -0.234 | -0.375 | -0.489 | -0.584 | -0.74 | -0.697 | -0.594 | -0.423 | -0.01 | 0.006 | -0.005 | 0.003 | 0.002 | -0.007 | 0 | 0 | 0 |
| Operating Expenses
| 22.044 | 20.16 | 20.769 | 24.012 | 20.032 | 21.561 | 21.852 | 22.124 | 23.173 | 25.679 | 26.08 | 35.364 | 34.715 | 30.713 | 23.183 | 18.48 | 15.028 | 12.879 | 10.344 | 8.148 | 6.999 | 3.841 | 3.046 | 2.36 | 1.754 | 1.754 |
| Operating Income
| -22.13 | -20.246 | -20.855 | -24.012 | -20.032 | -21.561 | -21.852 | -22.124 | -23.173 | -25.679 | -26.08 | -35.364 | -34.715 | -30.713 | -23.183 | -18.48 | -15.028 | -12.879 | -10.344 | -8.148 | -6.999 | -3.841 | -3.046 | -2.339 | -1.76 | -1.76 |
| Operating Income Ratio
| 0 | 0 | -4.261 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.221 | 2.021 | 1.447 | 1.005 | 0.341 | 0.686 | 3.024 | 0.47 | 0.243 | 0.172 | -0.375 | -0.489 | -0.584 | -0.74 | -0.697 | -0.594 | -0.423 | -0.01 | 0.029 | -1.121 | -5.297 | 0.002 | -0.022 | -0.021 | 0.007 | 0.007 |
| Income Before Tax
| -19.909 | -18.225 | -19.408 | -23.007 | -19.152 | -20.875 | -18.828 | -21.654 | -22.93 | -25.507 | -25.867 | -35.077 | -34.351 | -30.301 | -22.626 | -17.912 | -14.571 | -12.145 | -9.875 | -9.268 | -12.287 | -3.828 | -3.066 | -2.36 | -1.753 | -1.753 |
| Income Before Tax Ratio
| 0 | 0 | -3.966 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.043 | 1.34 | -0.115 | -0.539 | -0.686 | -1.778 | -1.032 | -0.629 | -0.578 | -125.683 | -0.489 | -0.584 | -1.152 | -0.712 | -0.594 | -0.422 | -0.744 | -0.472 | -0.005 | 0.003 | -0.011 | -0.007 | 0 | 0 | 0 |
| Net Income
| -19.909 | -18.225 | -19.408 | -23.007 | -19.152 | -20.189 | -17.05 | -20.622 | -22.301 | -24.929 | -25.867 | -35.077 | -34.351 | -30.301 | -22.626 | -17.912 | -14.571 | -12.145 | -9.875 | -9.268 | -12.287 | -3.828 | -3.066 | -2.36 | -1.753 | -1.753 |
| Net Income Ratio
| 0 | 0 | -3.966 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.36 | -0.35 | -0.38 | -0.45 | -0.52 | -0.55 | -0.47 | -0.57 | -0.61 | -0.69 | -0.71 | -0.97 | -0.95 | -0.84 | -0.63 | -0.5 | -0.41 | -0.51 | -0.3 | -0.66 | -0.88 | -0.27 | -0.22 | -1.16 | -0.87 | -0.87 |
| EPS Diluted
| -0.36 | -0.35 | -0.38 | -0.45 | -0.52 | -0.55 | -0.47 | -0.57 | -0.61 | -0.69 | -0.71 | -0.97 | -0.95 | -0.84 | -0.63 | -0.5 | -0.41 | -0.51 | -0.3 | -0.66 | -0.88 | -0.27 | -0.22 | -1.16 | -0.87 | -0.87 |
| EBITDA
| -22.044 | -20.16 | -20.769 | -24.012 | -19.918 | -21.561 | -24.084 | -21.995 | -23.045 | -25.554 | -25.867 | -35.034 | -34.331 | -30.694 | -22.626 | -17.898 | -14.557 | -12.869 | -10.367 | -8.139 | -6.974 | -3.829 | -3.039 | -2.328 | -1.749 | -1.749 |
| EBITDA Ratio
| 0 | 0 | -4.244 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |